1. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
- Author
-
Priya Velu, David Danko, Alain C. Borczuk, Michael Bailey, Daniela Bezdan, Craig Westover, Charles Y. Chiu, Evan Sholle, Tyler Hether, Peter A D Steel, Dorottya Nagy-Szakal, Yale A. Santos, Justyna Gawrys, Jeffrey A. Rosenfeld, Krista Ryon, Fritz J. Sedlazeck, Vijendra Ramlall, Amos J Shemesh, Cem Meydan, Shawn Levy, Angelika Iftner, Undina Gisladottir, Chandrima Bhattacharya, Robert E. Schwartz, Venice Servellita, Dianna Ng, Nikolay A. Ivanov, Massimo Loda, Arkarachai Fungtammasan, Jean Thierry-Mieg, Lars F. Westblade, Ying Chen, Joel Rosiene, Marcin Imielinski, Ebrahim Afshinnekoo, Joseph E. Barrows, Matthew MacKay, Chen-Shan Chin, Daniel Butler, Dong Xu, Sarah Warren, Jonathan Foox, Ciaran Hassan, Heather L. Wells, Andrea Granados, Lin Cong, Thomas R. Campion, Ari Melnick, Alon Shaiber, John Sipley, Sagi Shapira, Jason Reeves, Elizabeth Sanchez, Christopher Mozsary, Melissa M. Cushing, Thomas Iftner, Arryn Craney, Iman Hajirasouliha, Maria A. Sierra, Youngmi Kim, Scot Federman, Nathan A. Tanner, Niamh B. O’Hara, Christopher E. Mason, Hanna Rennert, Edward J. Schenck, Nicholas P. Tatonetti, Mirella Salvatore, Mara Couto-Rodriguez, Nathaniel M. Pearson, Benjamin Young, Michael Zietz, Shixiu Wu, Dmitry Meleshko, Jenny Xiang, Bradley W. Langhorst, P. Ruggiero, Danielle Thierry-Mieg, and Diana Pohle
- Subjects
0301 basic medicine ,Male ,viruses ,General Physics and Astronomy ,RNA-Seq ,Angiotensin-Converting Enzyme Inhibitors ,Disease ,Transcriptome ,0302 clinical medicine ,HLA Antigens ,2.1 Biological and endogenous factors ,Drug Interactions ,Viral ,Aetiology ,Lung ,Multidisciplinary ,Genome ,Middle Aged ,Infectious Diseases ,Molecular Diagnostic Techniques ,5.1 Pharmaceuticals ,COVID-19 Nucleic Acid Testing ,Pneumonia & Influenza ,Female ,Development of treatments and therapeutic interventions ,Infection ,Nucleic Acid Amplification Techniques ,Adult ,Science ,Genome, Viral ,Biology ,Antiviral Agents ,Article ,General Biochemistry, Genetics and Molecular Biology ,Virus ,Vaccine Related ,03 medical and health sciences ,Angiotensin Receptor Antagonists ,Rare Diseases ,Clinical Research ,Biodefense ,Humans ,Pandemics ,Aged ,Host Microbial Interactions ,SARS-CoV-2 ,Gene Expression Profiling ,Prevention ,Outbreak ,COVID-19 ,General Chemistry ,Nucleic acid amplification technique ,Omics ,COVID-19 Drug Treatment ,Gene expression profiling ,030104 developmental biology ,Emerging Infectious Diseases ,Good Health and Well Being ,Immunology ,New York City ,030217 neurology & neurosurgery - Abstract
In less than nine months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) killed over a million people, including >25,000 in New York City (NYC) alone. The COVID-19 pandemic caused by SARS-CoV-2 highlights clinical needs to detect infection, track strain evolution, and identify biomarkers of disease course. To address these challenges, we designed a fast (30-minute) colorimetric test (LAMP) for SARS-CoV-2 infection from naso/oropharyngeal swabs and a large-scale shotgun metatranscriptomics platform (total-RNA-seq) for host, viral, and microbial profiling. We applied these methods to clinical specimens gathered from 669 patients in New York City during the first two months of the outbreak, yielding a broad molecular portrait of the emerging COVID-19 disease. We find significant enrichment of a NYC-distinctive clade of the virus (20C), as well as host responses in interferon, ACE, hematological, and olfaction pathways. In addition, we use 50,821 patient records to find that renin–angiotensin–aldosterone system inhibitors have a protective effect for severe COVID-19 outcomes, unlike similar drugs. Finally, spatial transcriptomic data from COVID-19 patient autopsy tissues reveal distinct ACE2 expression loci, with macrophage and neutrophil infiltration in the lungs. These findings can inform public health and may help develop and drive SARS-CoV-2 diagnostic, prevention, and treatment strategies.
- Published
- 2021